Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 933 to 982 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 159.165\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 164.951\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03635\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolar rna-associated protein alpha isoform. [source:refseq;acc:nm\_022917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 242.024\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.544\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03631\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sirtuin 7; sir2-related protein type 7; sirtuin type 7; sirtuin (silent mating type information regulation 2, s.cerevisiae, homolog) 7; silent mating type information regulation 2, s.cerevisiae, homolog 7; sirtuin silent mating type information regulation 2 homolog 7 (s. cerevisiae). [source:refseq;acc:nm\_016538]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 232.473\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 224.372\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03611\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor 3a subunit 3 (spliceosome associated protein 61) (sap 61) (sf3a60). [source:swissprot;acc:q12874]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 220.246\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.618\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03588\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor 3 subunit 1 (spliceosome associated protein 114) (sap 114) (sf3a120). [source:swissprot;acc:q15459]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent breast cancer type 1 susceptibility protein. [source:swissprot;acc:p38398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.501\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.27\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.088\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03586\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent swi/snf-related, matrix-associated, actin-dependent regulator of chromatin subfamily f member 1 (swi-snf complex protein p270) (b120). [source:swissprot;acc:o14497]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.437\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.083\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent grancalcin. [source:swissprot;acc:p28676]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 212.442\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.088\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 205.087\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.437\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.083\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.085\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone h4. [source:swissprot;acc:p02304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 227.765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.902\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03576\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03567\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent target of myb protein 1. [source:swissprot;acc:o60784]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.254\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03541\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent huntingtin-associated protein-interacting protein (duo protein). [source:swissprot;acc:o60229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.253\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.826\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0354\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 950\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-repair protein complementing xp-g cells (xeroderma pigmentosum group g complementing protein) (dna excision repair protein ercc-5). [source:swissprot;acc:p28715]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 252.873\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 261.821\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03539\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent triple functional domain protein (ptprf interacting protein). [source:swissprot;acc:o75962]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.253\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.827\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent target of myb1-like 2; target of myb1 (chicken) homolog-like 2. [source:refseq;acc:nm\_144678]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.252\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03537\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 198.494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03512\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 267.447\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 276.773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03487\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial 60s ribosomal protein l27 (l27mt) (hspc250). [source:swissprot;acc:q9p0m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 231.163\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 239.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03479\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vinexin (sh3-containing adaptor molecule-1) (scam-1). [source:swissprot;acc:o60504]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 211.812\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03458\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 129.913\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 134.399\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03453\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 129.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 134.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03452\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein beta subunit-like protein 12.3 (p205) (receptor of activated protein kinase c 1) (rack1) (receptor for activated c kinase). [source:swissprot;acc:p25388]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 237.558\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 229.677\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03431\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zuotin related factor-1 (m-phase phosphoprotein 11). [source:swissprot;acc:q99543]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 130.066\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 134.527\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0343\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent partitioning defective-6 homolog gamma (par-6 gamma) (par6d). [source:swissprot;acc:q9byg4]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 211.987\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 204.964\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03426\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby protein homolog. [source:swissprot;acc:p50607]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, iota type (ec 2.7.1.37) (npkc-iota) (atypical protein kinase c-lamda/iota) (apkc-lambda/iota). [source:swissprot;acc:p41743]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent numb protein homolog (h-numb) (protein s171). [source:swissprot;acc:p49757]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tbc1 domain family member 5. [source:swissprot;acc:q92609]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby related protein 1 (tubby-like protein 1). [source:swissprot;acc:o00294]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar protein sorting 29 (vesicle protein sorting 29) (hvps29) (mds007) (pep11) (dc7/dc15). [source:swissprot;acc:q9ubq0]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent numb-like protein (numb-r). [source:swissprot;acc:q9y6r0]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubby related protein 3 (tubby-like protein 3). [source:swissprot;acc:o75386]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar protein sorting 35 (vesicle protein sorting 35) (hvps35) (maternal-embryonic 3). [source:swissprot;acc:q96qk1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent t-cell activation wd repeat protein. [source:refseq;acc:nm\_139281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 243.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03407\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prefoldin subunit 5 (c-myc binding protein mm-1) (myc modulator 1). [source:swissprot;acc:q99471]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 228.953\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 221.421\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03402\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gcn5-like protein 1 (rt14 protein). [source:swissprot;acc:p78537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 202.027\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 195.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03399\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 130.289\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 134.713\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03396\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 200.398\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03387\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cirhin; testis expressed gene 292; cirrhosis, autosomal recessive 1a. [source:refseq;acc:nm\_032830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 243.312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03383\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/